James J. Burns & Company LLC Acquires 5,000 Shares of Tempus AI, Inc. (NASDAQ:TEM)

James J. Burns & Company LLC raised its stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 71.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 12,000 shares of the company's stock after buying an additional 5,000 shares during the period. James J. Burns & Company LLC's holdings in Tempus AI were worth $579,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Wells Fargo & Company MN increased its position in Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock worth $80,000 after buying an additional 278 shares in the last quarter. Operose Advisors LLC purchased a new stake in Tempus AI during the 4th quarter valued at approximately $25,000. Prestige Wealth Management Group LLC grew its stake in Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock valued at $36,000 after acquiring an additional 965 shares in the last quarter. Farther Finance Advisors LLC purchased a new position in shares of Tempus AI during the fourth quarter valued at about $34,000. Finally, First Horizon Advisors Inc. grew its holdings in Tempus AI by 207.9% during the 4th quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company's stock valued at $55,000 after buying an additional 1,108 shares in the last quarter. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Tempus AI Trading Up 0.3%

Shares of TEM stock traded up $0.15 during trading hours on Friday, reaching $54.58. 14,044,467 shares of the stock were exchanged, compared to its average volume of 6,679,126. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $91.45. The company's 50-day moving average price is $52.07 and its 200-day moving average price is $51.79. The firm has a market capitalization of $9.45 billion and a price-to-earnings ratio of -7.00. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.03. The business had revenue of $255.74 million for the quarter, compared to analysts' expectations of $248.13 million. The business's revenue was up 75.4% compared to the same quarter last year. As a group, equities analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms recently weighed in on TEM. William Blair reissued a "market perform" rating on shares of Tempus AI in a report on Tuesday, February 25th. Morgan Stanley lifted their price objective on shares of Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. Wolfe Research cut shares of Tempus AI from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Needham & Company LLC reissued a "buy" rating and issued a $70.00 price objective on shares of Tempus AI in a research note on Wednesday, May 7th. Finally, TD Cowen reiterated a "buy" rating and issued a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Six analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $63.42.

Insider Activity at Tempus AI

In other Tempus AI news, CFO James William Rogers sold 23,121 shares of the business's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $63.27, for a total value of $1,462,865.67. Following the completion of the sale, the chief financial officer now directly owns 146,001 shares of the company's stock, valued at $9,237,483.27. The trade was a 13.67% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Andrew Polovin sold 13,135 shares of the business's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $45.98, for a total value of $603,947.30. Following the completion of the sale, the executive vice president now owns 154,171 shares of the company's stock, valued at $7,088,782.58. The trade was a 7.85% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 723,042 shares of company stock worth $37,642,690 in the last quarter. 27.60% of the stock is owned by company insiders.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.